Gilead Pharma corp withdraws investment arbitration after Ukraine agrees to settlement of dispute over monopoly rights to market anti-viral drug

5-abril-2017

Ukraine has settled a dispute with American pharmaceutical company Gilead Sciences Inc., following the company’s pursuit of legal remedies in both domestic courts and via investment arbitration.

Incluir un comentario

¿Quién eres?
Tu mensaje
  • Para crear párrafos, deja simplemente líneas vacías.